Joseph R. Shaw: Join The Annual CanVECTOR National Thrombosis Seminar on Precision in DOAC Reversal
Joseph R. Shaw, Director of Research+ Program at Ottawa Department of Medicine, EHJ-CVP Associate Editor at European Heart Journal, shared on LinkedIn about a recent article published in JTH, adding:
”In my role as Chair of the CanVECTOR National Thrombosis Seminars, I’m pleased to share the final seminar of our 2025–2026 academic year.
Join us for: Working Towards Precision in DOAC Reversal Through Harnessing the Power of a National, Trainee-Led Network in the UK
Monday, June 8, 2026 | 12:00–12:45 p.m. ET
Featuring Richard Buka, PhD, MBChB, University of Birmingham.
This session will examine what ‘precision’ in DOAC reversal looks like in real-world practice, including not only the choice of reversal strategy, such as andexanet alfa, idarucizumab, and 4-factor prothrombin complex concentrate (4F-PCC/PCC), but also administration logistics, timing, dosing, patient selection, governance, and the potential role of urgent DOAC drug levels.
The discussion will draw on insights from the HaemSTAR trainee-led network and the JTH paper, ‘A UK-wide analysis of 2265 patients receiving a reversal agent for direct oral anticoagulant-associated bleeding.’
Moderator: Joseph R. Shaw, MD MSc FRCPC DRCPSC (Ottawa Hospital Research Institute)
A QandA session will follow the presentation.”
Title: A UK-wide analysis of 2265 patients receiving a reversal agent for direct oral anticoagulant-associated bleeding
Authors: HaemSTAR Collaborators
Stay updated on all scientific advances with Hemostasis Today.
-
May 26, 2026, 02:34James O’Donnell Secures 2 Million Euros for a New Programme on The Irish ABO and Coagulation Study – RCSI
-
May 26, 2026, 01:42Mili Doshi: The Role of Oral Health Teams in Supporting Stroke Rehabilitation and Recovery
-
May 26, 2026, 01:25Mohamed Mamdouh: Advancing Stroke Care Access in Cairo Through the Launch of a New Stroke-Ready Center
-
May 26, 2026, 01:15Tom Lazenby: Accelerating Rare Disease Drug Development Through MHRA’s Investigational Marketing Authorisation
-
May 25, 2026, 22:15Cedric Hermans: What Is Still To Be Discovered and To Be Redefined in The Treatment of Haemophilia A?
-
May 25, 2026, 16:27Gashaw Arega: Advancing Bleeding Disorders Care in Africa
-
May 25, 2026, 16:20Ai Phi Thuy Ho: Varicose Veins Show How Blood Flow Inside the Body Affects What You See on the Skin
-
May 25, 2026, 16:11Ashraf Ali Alsmadi: Recognizing the Difference Between Air Embolism and Pulmonary Embolism
-
May 25, 2026, 16:07Jeanett Mphume: Lymphedema and the Importance of Early Diagnosis